The idea of a "kill batch" being spread around, while other batches don't seem to be as deadly has multiple problems with it.
As I mentioned earlier, the primary issue is reporting, if some batch goes to some place where there are high likelihood of reporting issues, and another doesn't, it will make the former look deadlier, even if they both have the same kill rate.
But there's other problems also. If one batch is 10 times the size of another batch, it might appear to be 10 times deadlier assuming there is consistency to the reporting of each.
To put it simply, we don't have enough data to draw any reliable conclusions regarding specific batches versus others. We do know overall that these vaccines are dangerous, and seem to be more dangerous and deadly than previous vaccines. But without knowing how many batches there are, the size of each one, where each one ended up going, what percentage of the batch remained in the US versus being shipped to other countries, reliable numbers on adverse affects and death, trying to draw statistical conclusions isn't feasible.
The idea of a "kill batch" being spread around, while other batches don't seem to be as deadly has multiple problems with it.
As I mentioned earlier, the primary issue is reporting, if some batch goes to some place where there are high likelihood of reporting issues, and another doesn't, it will make the former look deadlier, even if they both have the same kill rate.
But there's other problems also. If one batch is 10 times the size of another batch, it might appear to be 10 times deadlier assuming there is consistency to the reporting of each.
To put it simply, we don't have enough data to draw any reliable conclusions regarding specific batches versus others. We do know overall that these vaccines are dangerous, and seem to be more dangerous and deadly than previous vaccines. But without knowing how many batches there are, the size of each one, where each one ended up going, what percentage of the batch remained in the US versus being shipped to other countries, reliable numbers on adverse affects and death, trying to draw statistical conclusions isn't feasible.